More on Revlimid

In Athens I had the opportunity to question Dr Giagounidis who was heavily involved in the MDS Revlimid trial about the 11 deaths that occurred in that trial. About half the deaths occurred in Germany. He went through them one by one and was able to satisfy me that they were all unrelated to the treatment apart from one patient who developed neutropenic sepsis.